참고문헌
- S. Bottcher, H. von Baum, T. Hoppe-Tichy, C. Benz and H.G. Sonntag, An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum, J. Pharm. Biomed. Anal., 25(2), 197-203 (2001) https://doi.org/10.1016/S0731-7085(00)00478-7
- F.A.Wong, S.J. Juzwin and S.C. Flor, Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human serum and urine, J. Pharm. Biomed. Anal., 15, 765-771 (1997) https://doi.org/10.1016/S0731-7085(96)01890-0
- K. Sato, Y. Matsuura, M. Inoue, T. Une, Y. Osada, H. Ogawa and S. Mitsuhashi, In vitro and in vivo activity of DL-8280, a new oxazine derivative, Antimicrob. Agents Chemother., 22, 548-553 (1982) https://doi.org/10.1128/AAC.22.4.548
- S. Djabarouti, E. Boselli, B. Allaouchiche, B. Ba, A.T. Nguyen, J.B. Gordien, J.M. Bernadou, M.C. Saux and D. Breilh, Determination of levofloxacin in serum, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method, J. Chromatogr. B., 799, 165-172 (2004) https://doi.org/10.1016/j.jchromb.2003.10.031
- H. Liang, M.B. Kays and K.M. Sowinski, Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human serum, J. Chromatogr. B, 772, 53-63 (2002) https://doi.org/10.1016/S1570-0232(02)00046-6
- T. Ohkubo, M. Kudo and K. Sugawara, Determination of ofloxacin in human serum by high-performance liquid chromatography with column switching, J. Chromatogr., 573, 289- 293 (1992) https://doi.org/10.1016/0378-4347(92)80131-9
- O. Okazaki, H. Aoki and H. Hakasui, High-performance liquid chromatographic determination of (S)-(-)-ofloxacin and its metabolites in serum and urine using a solid-phase clean-up, J. Chromatogr., 563, 313-322 (1991) https://doi.org/10.1016/0378-4347(91)80037-D
- J. Macek and P. Ptacek, Determination of ofloxacin in human serum using high-performance liquid chromatography and fluorescence detection, J. Chromatogr. B Biomed. Appl., 673(2), 316-319 (1995) https://doi.org/10.1016/0378-4347(95)00263-5
- E.M. Grant, M. Zhong, J.F. Fitzgerald, D.P. Nicolau, C. Nightingale and R. Quintiliani, Lack of interaction between levofloxacin and oxycodone: pharmacokinetics and drug disposition, J. Clin. Pharmacol., 41(2), 206-209 (2001) https://doi.org/10.1177/00912700122009890
- A. Lubasch, I. Keller, K. Borner, P. Koeppe and H. Lode, Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers, Antimicrob. Agents Chemother.,. 44(10), 2600-2603 (2000) https://doi.org/10.1128/AAC.44.10.2600-2603.2000
- S.C. Chien, F.A. Wong, C.L. Fowler, S.V. Callery-D'Amico, R.R. Williams, R. Nayak and A.T. Chow, Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers. Antimicrob, Agents. Chemother., 42(4), 885-888 (1998)
- M. Furlanut, L. Brollo, E. Lugatti, E. Di Qual, F. Dolcet, G. Talmassons and F. Pea, Pharamcokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections, J. Antimicrob. Chemother., 51, 101-106 (2003) https://doi.org/10.1093/jac/dkg035
- L. Shargel and A.B.C. Yu, Chapter 10. Bioavailability and bioequivalence, In Applied biopharmaceutics and Pharmacokinetics, 3rd ed., p. 193, Appleton & Lange, Nowwalk, USA (1993)